Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Neuropharmacology. 2013 May 17;73:19–30. doi: 10.1016/j.neuropharm.2013.05.001

Table 1.

Comparison of EC50 values for DA release

Genotype EC50 (mM) for
Total DA
release
EC50 (mM) for
α4β2-mediated
α-CtxMII-
resistant
EC50 (mM) for
α6β2-mediated
α-CtxMII-sensitive
+/+ ACh 0.41 ± 0.06 0.72 ± 0.11 0.14 ± 0.04
+/Leu9′Ala ACh 0.22 ± 0.07 * 0.30 ± 0.06 * 0.13 ± 0.11
Leu9′Ala/Leu9′Ala ACh 0.14 ± 0.05 * 0.08 ± 0.05 *+ 0.24 ± 0.15
+/+ Nic 2.59 ± 0.13 4.16 ± 0.33 0.91 ± 0.12
+/Leu9′Ala Nic 1.66 ± 0.15 * 1.74 ± 0.36 * 0.71 ± 0.16
Leu9′Ala/Leu9′Ala Nic 0.57 ± 0.10 *+ 0.52 ± 0.12 *+ 0.73 ± 0.24
*

Significantly different from +/+

+

Significantly different from +/Leu9′Ala